Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

MLA

Preiss, David, et al. “Eplerenone and New-Onset Diabetes in Patients with Mild Heart Failure: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).” European Journal of Heart Failure, vol. 14, no. 8, Aug. 2012, pp. 909–15. EBSCOhost, https://doi.org/10.1093/eurjhf/hfs067.

APA

Preiss, D., van Veldhuisen, D. J., Sattar, N., Krum, H., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., Pitt, B., Zannad, F., & McMurray, J. J. V. (2012). Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14(8), 909–915. https://doi.org/10.1093/eurjhf/hfs067

Chicago

Preiss, David, Dirk J. van Veldhuisen, Naveed Sattar, Henry Krum, Karl Swedberg, Harry Shi, John Vincent, et al. 2012. “Eplerenone and New-Onset Diabetes in Patients with Mild Heart Failure: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).” European Journal of Heart Failure 14 (8): 909–15. doi:10.1093/eurjhf/hfs067.